Bioptik Technology Incorporation Stock
Equities
4161
TW0004161005
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.25 TWD | 0.00% | +0.59% | +6.53% |
Sales 2022 | 768M 23.57M 32.17M | Sales 2023 | 829M 25.43M 34.72M | Capitalization | 1.7B 52.28M 71.38M |
---|---|---|---|---|---|
Net income 2022 | 48M 1.47M 2.01M | Net income 2023 | 85M 2.61M 3.56M | EV / Sales 2022 | 2.13 x |
Net Debt 2022 | 276M 8.46M 11.55M | Net Debt 2023 | 74.28M 2.28M 3.11M | EV / Sales 2023 | 2.15 x |
P/E ratio 2022 |
28.2
x | P/E ratio 2023 |
19.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.62% |
1 week | +0.59% | ||
Current month | -4.60% | ||
1 month | -6.55% | ||
3 months | +7.87% | ||
6 months | +14.36% | ||
Current year | +6.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chin Chang Yang
CEO | Chief Executive Officer | - | 00-08-20 |
Shu Ling Chen
DFI | Director of Finance/CFO | - | 15-01-08 |
Yao Jen Tu
IRC | Investor Relations Contact | - | 01-04-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ching Chang Wen
BRD | Director/Board Member | 74 | 10-11-14 |
Tun Jen Cheng
BRD | Director/Board Member | - | 09-06-29 |
Nai Ming Liu
BRD | Director/Board Member | - | 11-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 34.25 | 0.00% | 129,295 |
24-04-25 | 34.25 | +0.44% | 87,060 |
24-04-24 | 34.1 | -0.29% | 103,646 |
24-04-23 | 34.2 | +1.79% | 151,969 |
24-04-22 | 33.6 | -1.32% | 109,298 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+6.53% | 55.63M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 4161 Stock